safety
Showing 9976 - 10000 of >10,000
Hidradenitis Suppurativa Trial (Upadacitinib, Placebo)
Not yet recruiting
- Hidradenitis Suppurativa
- Upadacitinib
- Placebo
- (no location specified)
May 26, 2023
Advanced Cancer Trial in San Diego (personalized vaccine, Pembrolizumab)
Active, not recruiting
- Advanced Cancer
- personalized vaccine
- Pembrolizumab
-
San Diego, CaliforniaUCSD Medical Center
Sep 20, 2022
Cicatricial Alopecia Trial in New York (PF-06651600)
Not yet recruiting
- Cicatricial Alopecia
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Sep 19, 2022
Healthy Participants Trial in Brussels (PF-07899895, Placebo)
Not yet recruiting
- Healthy Participants
- PF-07899895
- Placebo
-
Brussels, Bruxelles-capitale, Région DE, BelgiumPfizer Clinical Research Unit - Brussels
Nov 14, 2023
Intervertebral Disc Disease Trial (Anterior Cervical Discectomy and Fusion)
Not yet recruiting
- Intervertebral Disc Disease
- Anterior Cervical Discectomy and Fusion
- (no location specified)
Feb 27, 2023
Healthy Volunteers Trial (QG101-23-0 capsules, Placebo)
Not yet recruiting
- Healthy Volunteers
- QG101-23-0 capsules
- Placebo
- (no location specified)
Dec 6, 2022
Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory, Advanced Solid Tumor Trial (TR115)
Not yet recruiting
- Non-Hodgkin's Lymphoma, Relapsed
- +2 more
- (no location specified)
Dec 6, 2022
COVID-19, Acute Respiratory Distress Syndrome Trial in Paris (Dornase Alfa Inhalation Solution [Pulmozyme], standard procedure)
Terminated
- COVID-19
- Acute Respiratory Distress Syndrome
- Dornase Alfa Inhalation Solution [Pulmozyme]
- standard procedure
-
Paris, FranceHôpital Fondation A. de Rotschhild
Dec 20, 2021
Spinal Cord Injury, Acute, Spinal Cord Injury at C4 Level With Complete Lesion, Spinal Cord Injury at C5-C7 Level With Complete
Recruiting
- Spinal Cord Injury, Acute
- +2 more
- Neural precursor cells derived from human embryonic stem cell line
-
Suwon, Gyeonggido, Korea, Republic of
- +1 more
May 3, 2022
Healthy Trial in Saint-Petersburg (Adalimumab (BCD-057), Adalimumab (Humira))
Completed
- Healthy
- Adalimumab (BCD-057)
- Adalimumab (Humira)
-
Saint-Petersburg, Russian FederationLLC BioEk
Oct 8, 2021
Castration-resistant Prostate Cancer Trial in Wuxi (Polaprezinc, Abiraterone)
Enrolling by invitation
- Castration-resistant Prostate Cancer
-
Wuxi, Jiangsu, ChinaJiangnan University
Sep 18, 2022
Sedation Trial in Beijing (Remimazolam Tosilate, Propofol)
Completed
- Sedation
- Remimazolam Tosilate
- Propofol
-
Beijing, ChinaPeking Union Medical College Hospital
Aug 19, 2022
Naloxegol US PMR CV Safety.
Active, not recruiting
- Opioid Induced Constipation
-
Wilmington, Delaware
- +1 more
Sep 14, 2021
Cryopyrin Associated Periodic Syndrome Trial in San Diego, Columbus (VTX2735)
Recruiting
- Cryopyrin Associated Periodic Syndrome
-
San Diego, California
- +1 more
Apr 11, 2023
Acute Ischemic Stroke Trial (XY03-EA, XY03-EA Placebo)
Not yet recruiting
- Acute Ischemic Stroke
- XY03-EA
- XY03-EA Placebo
- (no location specified)
Aug 24, 2022
Non-hodgkin Lymphoma,B Cell, Refractory DLBCL, Relapsed DLBCL Trial in United States (MT-3724, Gemcitabine, Oxaliplatin)
Terminated
- Non-hodgkin Lymphoma,B Cell
- +2 more
- MT-3724
- +2 more
-
Orange, California
- +8 more
Jul 18, 2022
Acute Myeloid Leukemia Trial in Worldwide (Cyclophosphamide-Fludarabine (Cy/Flu), oNKord®)
Recruiting
- Acute Myeloid Leukemia
- Cyclophosphamide-Fludarabine (Cy/Flu)
- oNKord®
-
Ghent, Belgium
- +9 more
Jun 15, 2022
Pneumococcal Infections, HIV Trial (PPV-23 Vaccine, PCV-13 Vaccine, Placebo Vaccine)
Withdrawn
- Pneumococcal Infections
- HIV Infections
- PPV-23 Vaccine
- +2 more
- (no location specified)
Oct 28, 2021
Hepatocellular Carcinoma Trial in Singapore (mRNA HBV/TCR T-cells)
Recruiting
- Hepatocellular Carcinoma
- mRNA HBV/TCR T-cells
-
Singapore, SingaporeSingapore General Hospital
Jun 27, 2022